Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

Go back to Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
(NASDAQ: CADL) Delayed: 10.68 --0 (-0%)
Previous Close $10.68    52 Week High
Open $10.68    52 Week Low
Day High $10.68    P/E N/A 
Day Low $10.68    EPS
Volume